Discover the latest and greatest in the world of cannabis products and services. Benzinga has got you covered with our weekly updates on the hottest new launches in the industry.
Poseida Therapeutics, Inc. (NASDAQ:PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced it is set to join both the
Needham cut the price target for Zebra Technologies Corporation (NASDAQ: ZBRA) from $385 to $340. Needham analyst James Ricchiuti maintained a Buy rating. Zebra Technologies shares fell 11.1% to close at $255.44 on Tuesday.